S-(+)-Rolipram reduces OA-induced bronchoconstriction with ID50 values of approximately 0
S3I-201 induces significant apoptosis in the representative human breast carcinoma cell line MDA-MB-435 and NIH 3T3/v-Src
4″-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by Sensitive and Resistant P388 Leukemia Cells
oral gavage twice daily for 2 days) exhibits fibrinolytic activity and dissolves blood clots in vivo
InChi: InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20
Progesterone Size:Solid 2 mg S-(+)-Rolipram reduces OA-induced bronchoconstriction withAKT inhibitor VIII, also known as AKTi 1 2, is a potent, selective and ell permeable, allosteric inhibitor of Akt 1 and 2, which efficiently inhibits CaMKI activity and aryl hydrocarbon receptor pathway. AKT inhibitor VIII suppresses hyperthermia induced Ndrg2 phosphorylation in gastric cancer cells. AKT inhibitor VIII displays good selectivity against a panel of 70 other kinases with micromolar inhibition against some kinases, for example, calcium